healthcare

Ozempic: A Miracle Drug or the Start of a Public Health Crisis?

(Source)   Ozempic, an injectable diabetes drug manufactured by Novo Nordisk, has recently increased in popularity and has caught the attention of celebrities and the general public alike. Known for its significant weight loss effects, Ozempic and similar products are changing how Americans approach nutrition, exercise, and body image. In addition to these potentially dangerous changes, the popularity of Ozempic exemplifies the potential dangers of off-label usage of drugs, as Ozempic’s intended audience struggles to access the medication due to its boom in popularity.   What is Ozempic, and how does it work? The Food and Drug Administration first approved Ozempic, a drug used to treat diabetes, in 2017. The active ingredient in Ozempic is semaglutide, which lowers blood sugar levels and regulates insulin, making it a crucial ingredient for those with type 2 diabetes. Semaglutide indirectly promotes weight loss as it imitates a naturally occurring hormone called glucagon-like peptide-1 that limits appetite by telling our bodies that we feel full and causes our stomachs to empty at a slower pace. Semaglutide makes patients feel fuller faster, and others have reported that their “food noise,”, or constant thoughts surrounding food, have disappeared after taking the drug. Ozempic is not the [read more]

Running Out of Beds: How COVID-19 Demonstrates the Need to Repeal State Certificate of Need Laws

(Source) During the onset of the COVID-19 pandemic in the United States, states struggled in part because the disease caused demand for hospital beds to outstrip supply. Around one month into the pandemic, in New York City, for example, only about 300 intensive care unit (“ICU”) beds remained available. States reacted by creating more medical facilities, and New York City mobilized public and private hospitals to create more beds and ICUs. The sudden spike in demand for medical care brought into question existing certificate of need laws. Certificate of need (“CON”) laws require anyone who wants to construct a new healthcare facility to obtain permission from the state first. The state often requires that the applicant pay a fee and establish that there is a public need. Many states also allow interested parties to object to the new facility. New York passed the first certificate of needs of law in the mid-1960s. The idea behind these laws was to allow states, instead of the market, determine whether there is a public need for additional medical facilities. In normal times, perhaps the idea of states restraining the spread of medical facilities may make sense. However, these laws hampered states’ responses to [read more]

Healthcare Price Transparency in a Privately Insured United States: Is Patient Ignorance Bliss?

(Source) It is no secret that the United States is the only industrialized nation without a single-payer universal healthcare program. Among the many issues created by the high cost of healthcare, both parties agree that unexpected, and often extremely expensive, medical bills present a serious threat to financial security in a nation where around two-thirds of individuals declare bankruptcy due to an inability to afford medical care. Despite both parties agreeing that surprise medical bills are a pressing issue, there is little agreement concerning what an appropriate solution might look like. On June 24, 2019, the Trump administration issued an executive order requiring hospitals to make negotiated pricing information accessible to the public. In November 2019, the Department of Health and Human Services, in complying with the order, created a “final rule” requiring all hospitals in the nation to publish the prices of certain procedures on their websites. The American Hospital Administration (“AHA”) and several other hospital networks subsequently filed a lawsuit challenging the administration’s authority to impose such a requirement. The AHA asserted that the rules imposed by this executive order would require more administrative positions to organize and deliver the requested pricing data, an increased cost that ultimately [read more]